Table 1.
Baseline Clinical Characteristics for All Participants and by Regimen
| All Participants (N=255) | NPH (n=112) | B-B (n=50) | CSII (n=93) | |
|---|---|---|---|---|
| Age (years) | 12.2 (9.0–15.0) | 12.4 (9.2–15.0) | 13.1 (9.0–15.0) | 11.8 (9.1–15.0) |
| Diabetes duration (years) | 4.4 (1.0–13.0) | 3.3 (1.0–13.0) | 4.4 (1.0–12.6) | 5.0 (1.0–12.0) |
| Sex (% female) | 51.4% | 55.4% | 44.0% | 50.5% |
| Race/ethnicity (% non-white) | 25.2% | 40.2% | 25.0% | 7.7% |
| zBMI (SDS) | 0.6±0.8 | 0.7±0.8 | 0.6±0.7 | 0.6±0.8 |
| Insulin dose (U/kg/day) | 0.9±0.3 | 1.0±0.3 | 1.0±0.3 | 0.9±0.2 |
| Blood glucose monitoring frequency (x/day) | 4.8±2.0 | 4.1±1.9 | 4.6±1.4 | 5.7±2.2 |
| A1C (mmol/mol) A1C (%) |
67±12 8.3±1.1 |
69±13 8.5±1.2 |
69±10 8.5±0.9 |
63±11 7.9±1.0 |
Values are in provided as mean±SD, median (range) (for diabetes duration and age), or percentage.